Most importantly, data presented here suggest that WWOX might modulate the NF-kB pathway triggered by PKC activation in epidermal keratinocytes which indicates that the involvement of WWOX could be a critical molecular event for the pathogenesis of psoriasis and that targeting WWOX could be a novel therapeutic approach for psoriasis in the future. The gene discussed is PRRT2; the disease is psoriasis.